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Abstract
Aquaculture in Chile has been practiced since the 1920s; however, it was not until the 
1990s that aquaculture became an important sector here. Important species in Chilean 
aquaculture include salmonids, algae, mollusks, and turbot. Salmonids are the dominant 
species in Chilean aquaculture for both harvest volume and export value, their produc-
tion reaching greater than 800-thousand tons in 2015. However, this growth has been 
accompanied by an increase in disease presence, requiring greater drug use to control. 
This increase in drug use is an environmental and public health concern for the authori-
ties, the salmon industry itself, and the destination markets. In this chapter, we review 
the literature on drug use, antibiotic resistance, regulatory framework, and alternatives, 
with focus on Chile.
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1. Introduction: brief history of antibiotics use in Chilean aquaculture
Antibiotics have been used to treat animals since the 1940s, which was soon followed by the 
appearance of resistant bacteria [1, 2]. In 1969, the House of Lords in the United Kingdom 
published the “Swann report,” highlighting the excessive use of antibiotics in animals and 
its potential risks to human and animal health. The Swan report suggested that antibiotic 
use should be restricted and regulated. The accumulated evidence from Europe and North 
America supports the notion that antibiotic use should be regulated and restricted to specific 
clinical situations [2].
In Chile, between 1973 and 1976, the first commercial fish farming of salmonids in the 
Region of the Lakes was consolidated and has grown ever since [3]. In the subsequent 
decades, four species of salmonids of commercial importance have been cultivated in 
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Chile: rainbow trout (Oncorhynchus mykiss), Chinook (Oncorhynchus tshawytscha), coho 
(Oncorhynchus kisutch), and Atlantic salmon (Salmo salar). In the period between 1987 and 
2010, four diseases appeared in the salmon farming industry in Chile, coinciding with the 
beginning of antibiotic use by the industry in 1989. The diseases reported in these years 
were primarily due to the ectoparasite Caligus and bacterial kidney disease in 1987 [4–6]; 
the presence of Piscirickettsia salmonis in 1989 [4]; presenting later high mortalities due to 
IPN in 1997; and by the outbreaks of the infectious salmon anemia disease in the years 
2002, 2007, and 2008 [5].
Sixteen antibiotics are used in animal treatments in Chile, compared to three in the United 
States (US) and four in Norway [7]. In the case of aquaculture in Chile, antibiotics have been 
mainly used in sea water Atlantic salmon farming, which accounted for 80% of the total use 
of antibiotics used for 2015, followed by 11% for coho salmon, 9% for rainbow trout, and 0% 
for Chinook salmon [8].
The consumption of antibiotics in the salmon industry in Chile has increased by 56% from 
2005 to 2015, with a production increase for those years of 23.48%. The highest consumption 
was recorded in 2014, with a total use of 563.2 tons of antibiotics with 955,179 tons of salmo-
nids produced. In 2016, there was a 30.66% decrease in antibiotic use compared to 2015, using 
a total of 382.5 tons of antibiotics to produce 727,812 tons of fish (Table 1) [8–11].
The most used antibiotics in the salmon farming industry in Chile are florfenicol and 
oxytetracycline. Florfenicol use has increased steadily since 2013 and accounted for 87% 
and 82.50% of the total antibiotics used in 2015 and 2016, respectively [8–11]. Florfenicol 
Year Antibiotics use annual quantity (ton) Annual production of salmonids (ton)
2005 239.1 614.435
2006 343.8 647.302
2007 385.6 600.862
2008 325.6 630.647
2009 184.4 474.174
2010 142.2 466.857
2011 206.8 649.492
2012 337.9 836.949
2013 450.7 786.091
2014 563.2 955.179
2015 557.2 846.163
2016 382.5 727.812
Table 1. Historical consumption of antibiotics in salmon farming industry in Chile [8–11].
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is mainly used in the seawater stage to control piscirickettsiosis (SRS) caused by the 
Gram-negative facultative intracellular pathogen P. salmonis. In salmonids, this epizootic 
disease has high mortality rates (78.9% for Atlantic salmon, 82.9% for rainbow trout, and 
59.3% for coho salmon) [9].
In 2005, SRS was the most diagnosed pathology, accounting for 77.04% of the antimicrobials 
used in the year 2005 by the industry [9]. This trend has been maintained; 89.3% of all antibiot-
ics used for the year 2016 have been for the control of SRS at the seawater stage followed by 
6.8% for the control of renibacterosis [10].
2. Antibiotic resistance
2.1. Mechanisms of P. salmonis infection
In the last decade, there have been significant advances in the knowledge of P. salmonis, 
including aspects of its survival behaviors under stress conditions and genomic data. One of 
the first achievements has been the culture of this pathogen in the cell-free medium [12, 13]; 
previously, it had been necessary to develop and maintain cultures of fish cell lines. This 
progress has allowed the study of the physiology and behavior of this bacterium. An inter-
esting recent finding is that P. salmonis can form biofilms. The development of P. salmonis 
biofilms occurs under stress conditions and salt concentrations similar to those of seawater. 
The biofilm matrix of P. salmonis is composed of exopolysaccharides and is disaggregated 
when treated with cellulases, which are relevant since biofilm formation might be a survival 
mechanism in the marine environment of this bacterium [14].
It is known that within biofilms, microorganisms are more resistant to the action of chemo-
therapeutics and have better survival rates under adverse conditions [15]. Recent findings 
have identified genes that have a role in the formation of P. salmonis biofilms such as the 
cheA gene [16]. This gene plays a key role in modulating the initiation of bacterial chemotaxis 
in other bacteria, such as Pseudomonas pseudoalcaligenes KF707 [17]. Using real-time PCR, it 
has been shown that cheA expression is increased during P. salmonis biofilm development. 
The results obtained in this research also suggest interaction between the formation of bio-
films and the genes involved in the chemotaxis of this pathogen. Biofilm production has been 
reported as a potential mechanism of pathogenicity in several aquatic bacteria [18, 19]. It is 
very likely that the first contact with fish for the development of biofilm is produced by che-
motactic responses. Chemotaxis to fish mucus has been previously reported as the first step 
in the development of pathogenic activity [20].
Some authors have suggested that P. salmonis infections begin when bacteria overgrow the 
skin barrier or gills [21]. In this regard, experimental infections were performed in juveniles of 
Oncorhynchus mykiss obtained from areas where the presence of SRS has never been reported, 
infecting them at six different entry sites. These authors found that the main entrance routes 
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are through skin and gills and that the oral route is not used to initiate P. salmonis infection 
of salmonids [22]. Later, this same research group performed experimental infections in coho 
salmon (Oncorhynchus kisutch). The results of cumulative mortality and survival analyses 
showed that the most effective entry portal was the skin, followed by intestinal intubation and 
finally by gill infection [23]. These findings show that P. salmonis can penetrate and then sys-
temically invade the Coho salmon through the skin and mucous membranes, which appear 
intact at the macroscopic level, and that the skin is probably the most important site of entry 
of this bacterium into salmonids. These findings support the notion that biofilm formation 
initiates colonization of the fish, thereby activating other virulence factors such as proteases 
to initiate ulcerations and invasion of the organism. P. salmonis is not a motile bacteria and a 
chemotaxis process could not be activated toward the fish mucus as it happens in other fish 
pathogens [20]. Studies have shown that other nonmotile pathogenic bacteria can adhere to 
their host through their net electrostatic charges [24]. Also, nonmotile pathogens infect a host 
using proteases, and the genes encoding these proteases can be transmitted to nonprotease 
mutant strains [24].
Recent research carried out on coding and noncoding transcript during an in vivo infection 
process of Atlantic salmon with P. salmonis identified a common response associated with 
oxidation-reduction processes, endocytosis, and ion responses. In the different types of ana-
lyzed tissues, the clathrin protein, which plays a major role in the formation of coated vesicles, 
was significantly upregulated in infected individuals, suggesting the importance of clathrin-
mediated endocytosis for the bacterial internalization. Moreover, several endocytosis recep-
tors were repressed during the challenge [25].
2.2. Piscirickettsia salmonis resistance to antibiotics
As mentioned above, the use of oxytetracycline and florfenicol are mostly used to control 
P. salmonis. Florfenicol use almost doubled between 2013 and 2016, suggesting that the bat-
tle against this pathogen has been unsuccessful. The evolution of resistance of P. salmonis 
to antibiotics has been demonstrated. Recent isolates of P. salmonis (SLGO94 and SLGO95) 
present a higher level of resistance to antibiotics than earlier isolates (LF-89 and EM-90), 
suggestive of antibacterial resistance [26]. Subsequently, a large-scale study conducted to 
evaluate the susceptibility profiles for quinolones, florfenicol, and oxytetracycline from 
292 field isolates obtained from different farm sites over a 5-year period revealed a high 
incidence of resistance to quinolones and early resistance to oxytetracyclines and florfeni-
col [27, 28].
P. salmonis genes encoding membrane-carrying proteins are upregulated in the presence of 
antibiotics [29]. The P. salmonis genome encodes efflux pumps that enable this bacterium 
to survive at critical concentrations of florfenicol [30]. Thus, despite the use of antibiotics, 
there are antibiotic-resistant (especially quinolone) bacteria in sediments near farming areas 
[31]. These bacteria carry plasmids that confer resistance to quinolones in marine bacteria 
[32]. Figure 1 shows a proposed model for P. salmonis infection during the seawater stage in 
salmonids.
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3. Analysis of the regulatory framework
In Chile, in its Article 86, the Fisheries and Aquaculture law prohibits the preventive appli-
cation of antimicrobials in a preventive way in aquaculture, as well as any use harmful 
to human health. Subsequently, there have also been the supreme decree N°319/2001, 
Regulation on Protection Measures for the Control and Eradication of High-Risk Diseases 
for Hydrobiological Species; the exempt resolution N°8228/2015 [33], the Manual of Good 
Practices in the Use of Antimicrobials and Antiparasitics in Chilean Salmon Farming [34]; 
the exempt resolution No 5.125/ 2016, Manual on Food Safety and Certification [35]; and 
the Quality Assurance Program (PAC) for Fisheries and Factories Vessels [36]. This reg-
ulatory framework is jurisdiction of SENAPESCA (National Fisheries and Aquaculture 
Service) institution that is part of and depends on the Ministry of Economy, Development 
and Tourism.
According to the current legislation, only pharmaceuticals for exclusive veterinary use regis-
tered or authorized for application in hydrobiological species can be used [37]. The pharma-
ceutical products authorized by Servicio Agrícola Ganadero (SAG) are shown in Table 2 [34]. 
The studies of effectiveness, adequate dosage, animal safety, and human food safety (toxicol-
ogy) of these authorized pharmaceutical products are not available to the public or were not 
found.
Figure 1. Model of in situ infection of P. salmonis. (A) Biofilms of P. salmonis in culture net; (B) biofilms in microaggregates; 
(C) transference of resistance genes in sediments; (D) colonization of P. salmonis on fish surface in captivity and onset of 
pathogenesis by contact with microaggregates or net. Elaborated by: Carlos Riquelme and Victor Sanchez.
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Generic name Trade name 
and registry 
no.
Presentation/route 
of administration
Registered by Withdrawal 
period 
(degree 
days)
Dose mg/kg 
lw*/day
Tolerance level in 
muscle tissue  
(μg kg−1)
Oxolinic acid 80% Reg. N°441 Powder/oral FAV S.A. 450 20 per 
10 days
100
Litoflox Reg 
N°648
Powder/oral Centrovet 
LTDA.
450 10–30 per 
10 days
Bandrol Reg 
N°481
Powder/oral Veterquímica 
S.A.
450 10 per 
10 days
Amoxicillin 50% Amox-Feed 
Reg N°121
Powder/oral Veterquímica 
S.A.
300 70.4 per 
10 days
50
Erythromycin 50% Vetromic Reg. 
N°1402-B
Powder/oral Centrovet 
LTDA.
500 75–100 per 
21 days
200
Erythromycin 80% Eritofeed 
Reg. N°616-B
Powder/oral Veterquímica 
S.A.
500 92.5 per 
21 days
Vetromic Reg 
N°1803-B
Powder/oral Centrovet 
LTDA
500 75–100 per 
14–21 days
Flumequine 10% Flumepren 
Reg. N°79
Powder/oral Centrovet 
LTDA
300 (−) ***500
****600
Flumequine 50% Reg. N°484 Powder/oral FAV S.A. 300 12–25 per 
10–12 days
Reg. N°646 Powder/oral Centrovet 
LTDA
300 12–30 per 
10 days
Flumequine 80% Reg. N°442 Powder/oral FAV S.A. 300 20 per 
10 days
Flox-Feed 
Reg. N°478
Powder/oral Veterquímica 
S.A.
300 10 per 
10 days
Flumepren 
Reg. N°645
Powder/oral Centrovet 
LTDA.
600 12–30 per 
10–15 days
Florfenicol 50% Florfenox 
Reg. N°1537
Powder/oral Bayer S.A. 300 10 per 
10 days
1000
Veterin Reg. 
N°1556
Powder/oral Centrovet 
LTDA.
300 10 per 
10 days
Duflosan 
Reg. N°1769
Powder/oral Veterquímica 
S.A.
300 10 per 
10 days
Florfenicol 50% Duflosan L 
Reg. N°2264
Solution/oral Veterquímica 
S.A.
100 10 per 
10 days
1000
Aquafen Reg. 
N°1193
Powder/oral Intervet Chile 
LTDA.
200 10 per 
10 days
Reg. N°1598 Powder/oral FAV S.A. 300 10 per 
10 days
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The Chilean authority supervises the use of pharmaceutical products in hydrobiological spe-
cies, and in accordance with the provisions of the general and specific health programs, ther-
apeutic treatments applied to populations of hydrobiological species should be prescribed 
by a veterinarian and the application of antimicrobials for prophylactic purposes is prohib-
ited. Before the application of the antimicrobials, fish samples should be obtained for sub-
sequent confirmation of the diagnosis by laboratory analysis [37]. Farming facilities should 
keep records of antimicrobial treatments performed and antimicrobial treatments should be 
reported monthly through the Aquaculture Inspection System (SIFA) [34].
Extralabel antimicrobials can be prescribed by a veterinarian when the health of an ani-
mal is at risk, there is danger of death, or there is suffering of the animal; or when one of 
the following is fulfilled: dosage, timing, duration of treatment or route of administration 
for a registered product does not obtain the expected response; the product is temporarily 
unavailable on the market; or there is no registered product to treat a diagnosed condi-
tion [34].
The Manual on Food Safety and Certification (resolution No 5.125/ 2016) describes the norms 
and procedures that allow to guarantee the sanitary quality of the fishery and aquaculture 
products destined for international markets along the whole productive chain. Regarding 
Generic name Trade name 
and registry 
no.
Presentation/route 
of administration
Registered by Withdrawal 
period 
(degree 
days)
Dose mg/kg 
lw*/day
Tolerance level in 
muscle tissue  
(μg kg−1)
Oxytetracycline 
hydrochloride 
20%
Terrivet F200 
Reg. N°2252
Suspension for 
injection
Veterquímica 
S.A.
1060 **20 200 (−) 
Tetracyclines
Oxytetracycline 
50%
Terrivet Reg. 
N°149
Powder/oral Veterquímica 
S.A.
600 75 per 
15 days
Oxytetracycline 
80%
Terrivet Reg. 
N°485
Powder/oral Veterquímica 
S.A.
600 75 per 
15 days
Reg. N°1595 Powder/oral FAV S.A. 600 55–82 per 
10 days
Zanil Reg. 
N°1380
Powder/oral Centrovet 
LTDA.
600 75 per 
10 days
Oxytetracycline 
40%
Reg. N°309 Powder/oral Laboratorio 
Veterinario 
Quimagro 
S.A.
600 13.57–20.75 
per 10 days
*lw = live weight.
**mg/kg/lw.
***Trout.
****Other salmonids.
Table 2. Antimicrobials for salmonids authorized by the Veterinary Medicines Registry (SAG) [34].
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the procedures for the control of residues of pharmaceutical products, each farm facility 
must demonstrate (and issue a declaration of guarantee) that the concentrations of resi-
dues of pharmaceutical products in fish do not exceed the limits established by the Chilean 
authority [35].
The analysis must be carried out in authorized laboratories, according to the Methods of 
Analysis of Residues of Pharmaceutical Products and Contaminants for Export Fishery 
Products. If the maximum allowable limits are not met, the withdrawal period should be 
extended and a new sampling should be carried out [35].
The government of Chile also maintains a Program of Surveillance and Control of 
Piscirickettsiosis, in which monitoring system and the application of control measures are 
established for this disease [38]. Upon request, the Chilean authority issues fish farming cen-
ters a certificate stating that the fish are free of antimicrobial and/or antiparasitic treatments 
[39]. The Quality Assurance Program (PAC) is a voluntary certification program, based on 
the concept of hazard analysis and critical control point (HACCP), which applies only to fish-
ing plants and factory vessels. This program, however, is mandatory for all companies that 
are authorized to export to the European Union and the United States. The Chilean author-
ity must approve the quality assurance plan for the industry and supervise its subsequent 
operation [36]. The administrative procedures, work guides, and specific requirements of this 
program (PAC) are not publicly available.
The main Chilean salmon markets are the US and Japan. In the case of the US, the Food and 
Drug Administration (FDA) is in charge of regulating the use of antibiotics in fish, primarily 
through its regulation 21 Code of Federal Regulations (CFR) 123 ‟Procedures for the Safe 
and Sanitary Processing and Importing of Fish,” which aims to ensure the safe and sani-
tary processing of fish and fishery products (seafood), including imported seafood [40]. The 
regulation mandates the application of HACCP principles to the processing of seafood as a 
preventive system of hazard control that can be used by processors to ensure the safety of 
their products to consumers. For the control of drugs for use in food of animal origin, direct 
medication or for addition to feed must be approved, conditionally approved, or index listed 
by the FDA (Federal Food, Drug, and Cosmetic Act Section 512) [41].
Under certain conditions authorized by FDA, unapproved new animal drugs may be used 
in conformance with the terms of an Investigational New Animal Drug (INAD) applica-
tion (21 CFR 511) [42] and FDA’s Center of Veterinary Medicine (CVM) guide 1240.3025. 
When a drug is approved by CVM, the condition of the approval is listed on its label or in 
the labeling (21 CFR 514.1) [43]; this condition specifies the species for which the drug is 
approved for use, indications for use, dosage regimen, and other limitations such as route of 
administration and withdrawal time. Labeled withdrawal times must be followed to ensure 
that no harmful drug residues are present in the edible tissue of the animal when harvested 
for human consumption; tolerances for some drug residues in the edible tissue have been 
established [44].
Relatively few drugs have been approved for aquaculture in the US (Table 3). This has led 
to the inappropriate use of unapproved drugs, general-purpose chemicals, or approved 
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Antibiotic Dose Approved for: Route of administration Tolerance level in 
muscle tissue
Withdrawal 
period
Terramycin 200 
(oxytetracycline 
dehydrate)
2.5–3.75 g/100 lb. of 
fish/day
Maximum 
dose = 8.33 mg/kg/
day/10 days
Salmonids: For control of ulcer disease caused by 
Haemophilus piscium, furunculosis caused by Aeromonas 
salmonicida, bacterial hemorrhagic septicemia caused 
by A. liquefaciens, and pseudomonas disease, for control 
of mortality due to cold-water disease associated 
with Flavobacterium psychrophilum. Freshwater-reared 
Oncorhynchus mykiss: For control of mortality due to 
columnaris disease associated with Flavobacterium 
columnare
Administer in mixed ration 
for 10 days; do not liberate 
fish or slaughter fish for 
food for 21 days following 
the last administration of 
medicated feed.
2 ppm (As 
the sum of 
tetracycline 
residues)
21 days 
for disease 
control in 
salmonids
7 days for 
marking 
skeletal 
tissue in 
Pacific 
salmon
OxyMarine 
Oxytetracycline HCL 
soluble powder-343, 
TETROXY Aquatic
200–700 mg 
oxytetracycline/L of 
water for 2–6 h
For marking of skeletal tissues in finfish fry and 
fingerlings as an aid identification
Immersion 2 ppm (as 
the sum of 
tetracycline 
residues)
21CFR 
556.500
Sulfadimethoxine/
ormetoprim 
combination 
Romet-30
For control of furunculosis in salmonids (trout and 
salmon) caused by Aeromonas salmonicida
Medicated feed 0.1 ppm for each 
drug (21 CFR 
556.490)
42 days 
(21 CFR 
558.575)
Florfenicol Aquaflor 10 mg/kg fish 
per day for 10 
consecutive days
For the control of mortality in freshwater-reared 
salmonids due to cold-water disease associated with 
Flavobacterium psychrophilum
Medicated feed 2 ppm in salmon 
muscle/skin
15 days
Table 3. FDA aquaculture approved drugs, route of administration, and tolerance levels [40, 44].
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drugs in a manner that deviates from the labeled instructions [44]. Studies establishing the 
effectiveness, adequate dosage, animal safety, and human food safety (toxicology) of these 
approved drugs are available to the public [45].
In the case of Japan, fishery products are regulated by the Food Sanitation Act and the Food 
Safety Basic Act. The authorities involved with in the Food Sanitation Act are as follows: the 
Office of Import Food Safety; Inspection and Safety Division; Pharmaceutical and Food Safety 
Bureau; Ministry of Health, Welfare and Labor; and the Department of Food Safety. The pur-
pose of the Food Sanitation Act is to prevent the occurrence of health hazard arising from 
human food so as to contribute to the protection of people health by conducting regulations 
and measures deemed necessary, from the view point of public health and for securing food 
safety [46].
The purpose of the Food Safety Basic Act is to promote comprehensive measures to secure 
food safety by laying down the basic principles of safety for food, defining the responsibility 
of the government, local authorities, and food-related businesses, clarifying the role of con-
sumers, and establishing basic policies for developing measures. The authority concerned is 
the Consumer Affair Agency [46].
Antibiotic residue concentrations for edible products from food-producing animals are 
determined based on jurisdictional-specific regulations that result in the determination 
of a tolerance or maximum residue level (MRL) for specific drugs in a specific tissue for 
specific animal species and based on toxicological assessments. This index estimates the 
amount of substance in food that can be ingested over a lifetime by humans without 
significant risk to health [47]. There are notable differences among MRLs or tolerances 
set by the different agencies regarding the two antibiotics most used in Chilean salmon 
farming (Table 4).
Many methods have been developed for analysis of antibiotics in fish. HPLC and mass 
spectrometry (HPLC-MS/MS) is the most sensitive method for the detection of these anti-
biotics and is currently regarded as the tool of choice for analysis of antibiotic residues in 
Antibiotic Europe (μg kg−1) MRL eChile (μg kg−1) fUSA tolerance (ppm) gJapan (ppm)
Oxytetracycline a100 200 c2 d0.2
Florfenicol b1000 1000 1 0.2
a508/1999/EC.
b1322/2001/EC.
cAs a sum of tetracycline residues [44].
dCalculated as oxytetracycline.
e[34].
f[44].
g[48].
Table 4. Antibiotics used in Chilean salmon farming and their maximum residue limits in salmonids (MRLs).
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animal-derived food [47, 49], having a limit of detection (LOD) in fish of 10.3 ng/l [50] and 
a limit of quantification of 20 ng/l for tetracyclines [51].
4. Alternative antibiotic treatment in salmon farming
Fish are considered as the earliest class of vertebrates to have both innate and adaptive 
immunity, though the latter defense mechanism is not as elaborate as in higher verte-
brates. Unlike in mammals, the alternative complement pathway in teleosts is relatively 
high and can mediate the lysis of target erythrocytes from several species. These features, 
along with their potential to function at varying temperatures, suggest that the comple-
ment system is a powerful defense mechanism in fish [52–54], and they are in constant 
interaction with their surroundings and therefore could easily encounter potential patho-
gens. In the wild, fish can protect themselves using innate defense mechanisms (either 
constitutive or responsive) [52].
The various alternatives to the use of antibiotics can be classified according to the action 
toward the pathogen or host. Pathogen-directed strategies include inhibitors of growth and 
virulence genes, antibacterial compounds, and the phage therapy. Host-directed strategies 
include the improvement of health, stress prevention, stimulation of the defense system, and 
selective breeding for disease resistance [55].
One of the first lines of defense against bacterial infection is the withholding of nutrients, 
termed nutritional immunity. The most significant form of nutritional immunity is the 
sequestration of iron [56]. Recent studies have detected a relationship between iron trans-
porter glycoproteins and Salmo salar susceptibility to pathogens [57, 58]. In salmonids, an 
iron transporter glycoprotein has been identified as a vaccine enhancer [59]. In vertebrates, it 
has been shown that iron transporter glycoproteins exert antibiofilm therapeutic [60, 61] and 
antimicrobial activity by binding to iron, thereby preventing its use by bacteria [61–64] and 
thus causing alterations in the bacterial wall and, ultimately, death. Because of its cationic 
nature, this glycoprotein binds to the lipopolysaccharides of Gram-negative bacteria, thereby 
attenuating those proinflammatory processes induced by bacterial lipopolysaccharides [63]. 
Among alternative sources of bioactive compounds, ingredients or products derived from 
marine algae show great potential for use in aquaculture [65]. Rainbow trout–supplemented 
diets with phytopharmaceutical of herbal and macroalgal origin have improved resistance 
against P. salmonis [66].
Several bacteriophages have been isolated against the following pathogenic bacteria, 
Edwardsiella tarda, Edwardsiella ictaluri, Lactococcus garvieae, Pseudomonas plecoglossicida, 
Streptococcus iniae, Flavobacterium columnare, Flavobacterium psychrophilum, Aeromonas sal-
monicida, Aeromonas hydrophila, Vibrio anguillarum, Vibrio harveyi, and Vibrio parahaemo-
lyticus, and their potential to be used as a therapeutic agent has been studied by several 
researchers [67]. In salmonids, Flavobacterium psychrophilum phages have shown protection 
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against bacterial cold water disease in in vitro conditions. Each phage isolate rarely infected 
F. psychrophilum strains other than the strain used for its enrichment and isolation. Some 
bacteriophages decrease mortality from intraperitoneal injection of their host strain when 
added together with the bacteria at a ratio of 10 plaque-forming units per colony-forming 
unit [68].
Promising results have been obtained in laboratory studies. However, high concentrations 
of bacteriophages in seawater can induce bacterial genetic variation. This occurs through 
mutation and bacteriophage-mediated horizontal transmission of genetic material between 
different bacteria mediated by bacteriophages [5, 69]. The use of phages can also influence 
bacterial community dynamics and ecosystem biogeochemistry. These influences differ 
depending on whether phages establish lytic, chronic, or lysogenic infections. The impacts 
of lysogeny are well studied at the cellular level, but ecosystem-level consequences remain 
underexplored [70].
Probiotics have been credited for producing improved nutrition, health benefits, reduced dis-
ease incidence, improving growth, health status, immunity, feed conversion, microbial bal-
ance, and water quality, as well as food production in an environmental-friendly way [71–73]. 
Probiotics in aquaculture can be live or dead preparations, including cellular/extracellular 
components of the microorganism(s), administered either as a feed supplement or to the rear-
ing water. Probiotics can be used to control a range of bacterial pathogens in various fish spe-
cies [69]. For example, rainbow trout (Oncorhynchus mykiss) were protected against Aeromonas 
salmonicida and Yersinia ruckeri when administered with dietary Carnobacterium maltaromati-
cum and C. divergens [72]. The efficacy of Carnobacterium sp. at reducing diseases caused by A. 
salmonicida, V. ordalii, and Y. ruckeri in salmonids has also been demonstrated [72]. However, 
there is no solid knowledge regarding the potential of probiotic against P. salmonis.
The Food and Agriculture Organization of the United Nations (FAO) has now highlighted the 
use of probiotics in aquaculture as a means of improving the quality of the aquatic environ-
ment [72]. However, concerns have been voiced about the possible acquisition of antibiotic 
resistance and virulence genes via horizontal gene transfer, which might lead to safety prob-
lems if using live probiotics in an open aquatic environment. Probiotics can also affect host 
tissue and result in severe cell damage. To avoid this, probiotic strains must be recognized as 
safe for the cellular integrity of the host [72].
In the aquaculture industry, vaccination strategies include traditional inactivated and attenu-
ated vaccines, as well as next-generation vaccines comprising recombinant, subunit, vectored, 
genetically engineered, DNA and peptide vaccines, reverse vaccinology, plant-based edible 
vaccines, and nanovaccines [74]. Current vaccination protocols for P. salmonis include whole 
cell, inactivated and adjuvant vaccines for injection (primary immunization), followed by oral 
boost (where the timing of boost delivery is determined by measuring circulating antibody 
levels against the pathogen). Live vaccines and DNA vaccine studies have been unsuccessful 
under laboratory conditions. There are more than 25 different vaccines against SRS that are 
available in the Chilean market. These vaccines confer good short-term protection against 
disease and mortality but are inefficient at conferring long-term protection, or the duration of 
protection is insufficient to protect the fish throughout their economic life [75–77].
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5. Conclusions
Veterinarians in charge of the salmon industry in Chile have used large quantities of anti-
biotics relative to its production volumes. In the years of highest production, an average 
of 600 g ton−1 produced was used. The antibiotics used by this industry are florfenicol and 
oxytetracycline for the control of P. salmonis at the seawater stage; studies have demonstrated 
the resistance of this pathogen to quinolones, oxytetracycline, and florfenicol, as well as their 
mechanisms of resistance.
There are 12 different types of generic and 25 branded antimicrobials authorized for use in 
salmonids in Chile, with no specifications related to pathogens or diseases. This is in contrast 
to the US situation, where the FDA has approved just four antibiotics for specific uses and 
against certain pathogens.
The studies of the effectiveness, adequate dosage, animal safety, and human food safety (toxi-
cology) of the authorized pharmaceutical products, as established by the Chilean authority, 
are not available to the public or were not found. This was also the case for the administra-
tive procedures, work guides, and specific requirements of the Quality Assurance Program 
(PAC), whereas the effectiveness and toxicology studies of the FDA-approved antibiotics are 
freely available online. This absence of Chilean regulation and antibiotic data is concerning. 
To avoid chemical hazards and ensure food safety, we propose that a mandatory legal frame-
work based on international regulations is needed in Chilean aquaculture. Antimicrobial 
treatment is required for an efficient production of animal products; however, antibiotics 
should never be used as a substitute for proper nutrition and hygiene management.
The alternatives to the use of antibiotics in Chilean salmon farming, such as the use of nutri-
tional immunity, phytopharmaceuticals, probiotics, antimicrobial peptides, and selective 
breeding for disease resistance, require advanced research with in vivo studies. Although 
several vaccines have been authorized, this remains an inefficient strategy for the control of 
pathogens in aquaculture.
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